Searches every page: governance library, books, services, glossary, tools, insights.
Daily briefing · 2026-08-14 · compiled Fri, 14 Aug 2026 01:25 UTC · 1-minute read
Amgen announced plans to establish a new Science and Innovation Center in Hyderabad's Genome Valley region, which will become part of the company's seven-laboratory global research network. The facility is expected to open in 2027 and will integrate advanced scientific capabilities with digital innovation to accelerate medicine discovery and development. Scientists and technologists will work across discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine at the center.
This expansion reflects Amgen's commitment to leveraging India's strong life sciences ecosystem and demonstrates Hyderabad's growing importance as a global research hub. The new center will work closely with Amgen's existing technology and innovation site in the same city, combining wet-laboratory science with advanced technology. Officials highlighted how this investment represents a significant step in establishing Hyderabad as a center for discovering and developing next-generation medicines for global patients.
Summarized from reporting first published by sanantoniopost.com. Read the original coverage.
This story was carried by 9 distinct outlets across 9 articles in the past 36 hours. Every source the pipeline found is listed below, unedited.
Grouped by day. The pipeline records publication dates, not times, so hour-level sequencing is not shown rather than estimated.
Coverage is discovery, never evidence. Where this story touches a law, framework, or requirement, the authoritative treatment lives in the AI Governance Reference Library, verified against primary sources. For the vocabulary, see the AI Glossary.